University of Alberta
The goal of this clinical trial is to learn about in brain "fog" complaints associated with long-COVID in people aged 22-50-years. The main questions it aims to answer are: the natural course of brain "fog" complaints the effect, if any of supplemental dietary oil on brain "fog" complaints Participants will be asked to undergo some brain testing (X-rays and questions. Treatments they'll be given will be one of two supplemental oils to consume daily. Researchers will compare outcomes in the two different oil groups to see if it has any effect on brain "fog" complaints.
Long COVID
medium chain triglyceride oil
Safflower oil
Not Applicable
Randomized placebo-control clinical trial comparing two types of nutritional oil and evaluating the impact, if any, on subjective complaints of long-COVID cognitive changes.}}
| Study Type : | Interventional |
| Estimated Enrollment : | 100 participants |
| Masking : | Quadruple |
| Masking Description : | Double-blind, placebo control |
| Primary Purpose : | Treatment |
| Official Title : | Nutritional Management of Post COVID-19 Cognitive Symptoms |
| Actual Study Start Date : | October 1, 2023 |
| Estimated Primary Completion Date : | March 30, 2025 |
| Estimated Study Completion Date : | March 1, 2026 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention Medium chain triglyceride oil 15ml tid x 5 months |
Dietary Supplement: medium chain triglyceride oil |
|
Placebo Comparator: Placebo Safflower oil 15mls tid x 5 months |
Dietary Supplement: Safflower oil |
| Ages Eligible for Study: | 22 Years to 50 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
University of Alberta
Edmonton, Alberta, Canada, T6G 2P4